SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-000035
Filing Date
2020-01-02
Accepted
2020-01-02 09:00:11
Documents
2
Period of Report
2020-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5915
2 EX-24 DOCUMENT attachment1.htm EX-24 3736
  Complete submission text file 0001209191-20-000035.txt   11050
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Issuer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MERUS N.V. YALELAAN 62 UTRECHT P7 3584 CM
Business Address
de Koning John (Reporting) CIK: 0001789849 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37773 | Film No.: 20500249